British American Tobacco stock edges up as buyback rolls on — what BATS investors watch next
14 January 2026
1 min read

British American Tobacco stock edges up as buyback rolls on — what BATS investors watch next

London, Jan 14, 2026, 08:52 GMT — Regular session

  • Shares of British American Tobacco climbed in early London trading following a new announcement of a share buyback
  • The company reported repurchasing 110,393 shares Tuesday and intends to cancel them
  • Attention now turns to the full-year results on Feb. 12 and the dividend schedule set for Feb. 4

Shares of British American Tobacco (BATS.L) ticked up 0.5% to 4,227 pence (£42.27) by 0850 GMT on Wednesday. The company revealed it repurchased 110,393 shares on Jan. 13 at a volume-weighted average price of 4,144.2212 pence. The buyback prices fluctuated between 4,115p and 4,201p. (Investing)

Buyback announcements carry extra weight these days as investors assess how much cushion share repurchases might provide ahead of the next earnings season. BAT’s full-year 2025 results are set for release on Feb. 12, according to its financial calendar. (Bat)

A buyback happens when a company buys back its own shares, usually cancelling them. This cuts the total shares outstanding and can boost per-share figures down the line. BAT said it will cancel the latest repurchase, leaving 2,178,417,781 shares outstanding, not counting treasury stock. (Investegate)

The stock closed Tuesday up 2.1% at £42.05, beating a flat FTSE 100 session, though it’s still roughly 14% off its 52-week peak reached last December, market data showed. (MarketWatch)

Imperial Brands (IMB.L), a major player in London’s tobacco sector, held steady Wednesday morning. The share price hovered around 3,009 pence, according to data. (Investing)

BAT investors face a key date soon: the next quarterly dividend payment on the London register is set for Feb. 4. Wednesday marks the final day to sign up for the dividend reinvestment plan ahead of that payout. (Bat)

Cash returns don’t eliminate the risks surrounding tobacco and nicotine companies. Volume and margin pressures can hit fast from regulation, excise taxes, or changes in consumer habits. Plus, a misstep with newer nicotine products would leave these stocks vulnerable.

Stock Market Today

  • Sotera Health valuation: shares near fair value amid momentum
    January 14, 2026, 4:23 AM EST. Sotera Health last closed at US$18.98. The stock shows a 30-day return of 12.77% and a 90-day rise of 16.8%, with a 1-year total shareholder return of 48.75% and a 5-year TSR of 24.53%. The analysis flags an intrinsic fair value of US$20.44 using an 8.72% discount rate, implying the shares are undervalued today. The consensus price target sits at US$16.00, with the most bullish at US$17.00 and the most bearish at US$14.00, underscoring disagreement on growth assumptions. At current levels, the stock trades at a P/E of about 97.3x versus Life Sciences peers at 61.1x and a broader fair multiple near 29.8x. Key risks: regulatory or litigation costs tied to ethylene oxide and higher compliance capex that could squeeze margins.
GSK stock ticks up after Summit cancer-trial tie-up — what investors watch next
Previous Story

GSK stock ticks up after Summit cancer-trial tie-up — what investors watch next

Go toTop